We are live on ! Find out more
NVS icon

Novartis

1,313 hedge funds and large institutions have $15.2B invested in Novartis in 2024 Q3 according to their latest regulatory filings, with 81 funds opening new positions, 414 increasing their positions, 484 reducing their positions, and 77 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more first-time investments, than exits

New positions opened: 81 | Existing positions closed: 77

0% more funds holding

Funds holding: 1,307 → 1,313 (+6)

0.23% less ownership

Funds ownership: 6.74% → 6.52% (-0.23%)

13% less funds holding in top 10

Funds holding in top 10: 15 → 13 (-2)

14% less repeat investments, than reductions

Existing positions increased: 414 | Existing positions reduced: 484

42% less call options, than puts

Call options by funds: $171M | Put options by funds: $294M

53% less capital inflows, than outflows

Capital inflows: $554M | Capital outflows: $1.18B

Holders
1,313
Holders Change
+6
Holders Change %
+0.46%
% of All Funds
18.78%
Holding in Top 10
13
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-13.33%
% of All Funds
0.19%
New
81
Increased
414
Reduced
484
Closed
77
Calls
$171​M
Puts
$294​M
Net Calls
-⁠$123​M
Net Calls Change
-⁠$96.4​M

NVS Hedge Fund Activity: Q3 2024 in Review

1,313 of the 6,990 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q3 2024, worth a combined $15.2B — up 3.7% from $14.7B a quarter earlier.

Buyers outnumbered sellers: 81 funds opened new NVS positions and 77 closed out — a net gain of 4 holders — while 414 added to existing stakes and 484 trimmed.

The largest buyer was Dimensional Fund Advisors, adding an estimated $77.8M. The largest seller was Magnetar Financial, exiting entirely with an estimated $139M sold.

  • 1,313 institutional investors held Novartis (NVS) as of Q3 2024, up from 1,307 in Q2 2024.
  • Funds reported $15.2B of Novartis stock for Q3 2024, up 3.7% quarter-over-quarter.
  • 81 funds opened new Novartis positions in Q3 2024 and 77 closed out, a net change of +4 holders.
  • The largest Novartis buyer in Q3 2024 was Dimensional Fund Advisors, an estimated $77.8M added.
  • The largest Novartis seller in Q3 2024 was Magnetar Financial, an estimated $139M sold.

Based on aggregated 13F filings for Q3 2024.